Horizon Pharma’s proposed acquisition of Depomed is the latest example of how companies that redomicile in lower-tax jurisdictions use this advantage in corporate takeovers.
The Continent’s most powerful country is grappling with its leadership role—and other nations are, too.
Hedge fund Elliott Management is bearing down in its campaign to block a controversial Samsung merger.
French oil-field services company Technip is aiming to cut its costs by 20%. That only adds to the uncertainty surrounding the sector.
MetWest Total Return Bond Fund, which benefited from outflows at Pimco following Bill Gross’s departure, is now moving to reduce risk.
Given the expected rise in interest rates, now may be a good time to adjust the size of a bond portfolio’s allocation and contents.
A big Vanguard ETF will build up holdings of China A shares, small-caps.
Do you remember Taylor Swift’s quote? Take our monthly funds and investing quiz.
Big U.S. stocks have given investors a remarkably smooth ride in recent years. That might lull some into complacency about the risk in their portfolios.
Greece doesn’t help, but China and Iran look like bigger factors explaining oil’s selloff.